Parasiticidal compositions comprising multiple active agents, methods and uses thereof
AssigneeMerial Limited
InventorsJoseph K. Rosentel, Jr., Monica Tejwani, Arima Das-Nandy
Life of this patent
Estimating the term…
Abstract
This invention relates to compositions for combating ectoparasites and endoparasites in animals, comprising at least one 1-arylpyrazole, at least one macrocyclic lactone, at least one insect growth regulator, and at least one anthelmintic compound in combination with a pharmaceutically acceptable carrier. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof.
Claims9
A topical veterinary composition for treating or preventing a parasitic infection or infestation in an animal comprising:
- (a) a combination of four active agents comprising,
- i. two contact-acting active agents, wherein one of the contact-acting active agents is fipronil and the other of the contact-acting active agents is an insect growth regulator active agent selected from the group consisting of (S)-methoprene, pyriproxyfen, hydroprene, cyromazine, fluazuron, lufenuron and novaluron;
- and
- ii. two systemically-acting active agents, wherein one of the systemically-acting active agents is praziquantel and the other of the systemically-acting active agents is a macrocyclic lactone active agent selected from the group consisting of eprinomectin, ivermectin, selamectin, milbemectin, milbemycin D, milbemycin oxime and moxidectin;
- (b) a pharmaceutically acceptable carrier comprising dimethylisosorbide and glycerol formal;
- and
- (c) optionally a crystallization inhibitor;
- wherein said composition is a liquid for topical administration;
- wherein fipronil is present in a concentration of about 5 to about 15% (w/v), the insect growth regulator active agent is present in a concentration of about 5 to about 15% (w/v), the macrocyclic lactone active agent is present in a concentration of about 0.01 to about 2% and praziquantel is present in a concentration of about 5 to about 15% (w/v);
- and
- wherein the composition exhibits broad spectrum efficacy against endoparasites and ectoparasites.
Dependencies are inferred from the claim text.